Connection

Patrick Flume to Clinical Trials as Topic

This is a "connection" page, showing publications Patrick Flume has written about Clinical Trials as Topic.
Connection Strength

0.619
  1. Efficacy measures for clinical trials: A review series. J Cyst Fibros. 2016 07; 15(4):415.
    View in: PubMed
    Score: 0.391
  2. Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration Workshop. Chest. 2021 02; 159(2):537-543.
    View in: PubMed
    Score: 0.131
  3. Medicinal treatment of intractable dyspnea in terminally ill patients. J S C Med Assoc. 2002 Aug; 98(4):196-9.
    View in: PubMed
    Score: 0.037
  4. Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment. J Cyst Fibros. 2021 01; 20(1):36-38.
    View in: PubMed
    Score: 0.033
  5. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017 06; 49(6).
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.